Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 29 Breast Neoplasms 28 Brain Neoplasms 21 Neoplasms 16 Glioma 10 Pancreatic Neoplasms 9 Head and Neck Neoplasms 8 Lymphoma 7 Uterine Cervical Neoplasms 6 Urinary Bladder Neoplasms 6 Rectal Neoplasms 6 Glioblastoma 6 Colonic Neoplasms 6 Carcinoma, Hepatocellular 6 Lymphoma, Non-Hodgkin 5 Lung Neoplasms 5 Astrocytoma 5 Triple Negative Breast Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Liver Neoplasms 4 Disease 4 Central Nervous System Neoplasms 4 Stomach Neoplasms 3 Spinal Cord Neoplasms 3 Sarcoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Esophageal Neoplasms 3 Carcinoma in Situ 3 Retinoblastoma 2 Pathologic Complete Response 2

Interventions

Etoposide 156 Carboplatin 146 Cisplatin 106 Topotecan 76 durvalumab 52 atezolizumab 51 Irinotecan 45 pembrolizumab 39 Paclitaxel 34 Nivolumab 33 Radiotherapy 31 PM 01183 25 Drug Therapy 24 anlotinib 23 Gemcitabine 21 apatinib 19 Ipilimumab 18 Docetaxel 17 Temozolomide 16 Platinum 16 Radiosurgery 15 Pemetrexed 14 toripalimab 13 tislelizumab 13 olaparib 13 Magnetic Resonance Spectroscopy 13 Bevacizumab 13 rovalpituzumab tesirine 11 amrubicin 11 Specimen Handling 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Small Cell Lung Carcinoma × Magnetic Resonance Imaging × Clear all

NCT04168281 2019-11-19

PCILESS

University of Warmia and Mazury in Olsztyn

Phase NA Unknown

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡